| 发明名称 |
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER |
| 摘要 |
This invention is directed to treatment of a subject having or suspected of having a cancer comprising administering to the subject a monoclonal antibody and NK-92 expressing Fc receptor. |
| 申请公布号 |
WO2016160602(A2) |
申请公布日期 |
2016.10.06 |
| 申请号 |
WO2016US24318 |
申请日期 |
2016.03.25 |
| 申请人 |
NANTKWEST, INC. |
发明人 |
LEE, Tien;KLINGEMANN, Hans G.;SIMON, Barry J.;BOISSEL, Laurent |
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
